A Double-blinded, Randomized, Two-way, Cross-over Study to Assess the Efficacy of Small Subcutaneous Glucagon Dose Against the Conventional 1 mg Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Pharmacodynamics; Therapeutic Use
- 04 Dec 2013 Biomarkers information updated
- 01 Dec 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 25 Apr 2013 New trial record